MRI Contrast Media Agents Market Size, Share and Forecast 2023-2030

Global MRI Contrast Media Agents Market Projected to Reach US$ 3.5 Billion by 2030 with a CAGR of 6.9%

The global market for MRI contrast media agents, which was valued at US$ 2.1 billion in 2022, is anticipated to experience substantial growth, reaching up to US$ 3.5 billion by 2030, according to the latest market analysis. The forecast period from 2023 to 2030 is expected to witness a Compound Annual Growth Rate (CAGR) of 6.9%.

MRI angiography, a key application, employs contrast chemicals to enhance the visibility of blood arteries. Gadolinium-based contrast agents, administered intravenously, play a crucial role in improving blood signal intensity, facilitating better delineation of vascular structures, and detecting anomalies such as aneurysms, stenoses, or vascular malformations.

Market Scope and Metrics:

CAGR: 6.9%
Size Available for Years: 2021-2030
Forecast Period: 2023-2030
Data Availability: Value (US$)
Segments Covered: Product, Type, Indication, End User
Regions Covered: North America, Europe, Asia-Pacific, South America, Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Report Insights Cover:
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.

Download Free sample: https://www.datamintelligence.com/download-sample/mri-contrast-media-agents-market

Market Dynamics:
Increasing Chronic Diseases Drive Growth
The surge in chronic diseases such as cancer, neurological disorders, cardiovascular disorders, and musculoskeletal ailments has propelled the demand for diagnostic imaging methods like MRI. The use of MRI contrast media agents significantly enhances the accuracy and sensitivity of MRI scans, aiding in the diagnosis and treatment monitoring of various disorders.

Despite overall health improvements, the World Health Organization (WHO) warns that if the current trend of non-communicable diseases persists, chronic diseases are projected to be responsible for 86% of the 90 million annual deaths by 2050.

Advances in Technology Fuel Market Growth
Continual advancements in Magnetic Resonance Imaging (MRI) technology contribute to the market's growth. MRI, known for its cutting-edge imaging capabilities, is continuously evolving. Functional MRI (fMRI), diffusion MRI, and MR angiography are examples of developments that enhance patient care and extend the possibilities of MRI.

Adverse Reactions Hamper Market Growth
While adverse reactions to MRI contrast media agents are rare, safety concerns exist. Allergic responses, including anaphylaxis, can occur. Some contrast agents pose a risk of nephrogenic systemic fibrosis (NSF) in patients with compromised kidney function, leading to cautious prescribing habits.

Segment Analysis:
The global MRI contrast media agents market is segmented based on type, product, indication, end-user, and region.

The Paramagnetic Agent Segment Dominates
The paramagnetic MRI contrast media agents segment held the highest market share at approximately 57.3% in 2022. These agents, altering T1 relaxation time, significantly impact T1-weighted imaging, enhancing image quality for areas of hypervascularity and related diseases.

To know more Insights: https://www.datamintelligence.com/research-report/mri-contrast-media-agents-market

Geographical Penetration:
North America Leads the Market
North America is projected to hold approximately 39.4% of the total market share throughout the forecast period. The aging population and the increasing prevalence of chronic diseases contribute to the region's dominant position.

Competitive Landscape:
Major global players in the market include GE Healthcare, Bracco Imaging SPA, Bayer AG, Guerbet, Lantheus Medical Imaging, Unijules Life Sciences, B. Chemicals and Pharmaceuticals Ltd., SANOCHEMIA Pharmazeutika GmbH, Taejoon Pharm, and Jodas Expoim among others.

By Product:
Paramagnetic Agents
Superparamagnetic Agents

By Type:
Clinical
Preclinical

By Indication:
Cancer
Gastrointestinal
Intravenous
Hepatobiliary
Neurological Imaging
Others

By End-user:
Hospitals
Diagnostic and Imaging Centers
Other

By Region:
North America: U.S., Canada, Mexico
Europe: Germany, U.K., France, Italy, Spain, Rest of Europe
South America: Brazil, Argentina, Rest of South America
Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific
Middle East and Africa

Related Reports:

MRI Contrast Media Agents Market: https://www.datamintelligence.com/research-report/mri-contrast-media-agents-market

MRI Systems Market: https://www.datamintelligence.com/research-report/mri-systems-market

Cardiac MRI Testing Market: https://www.datamintelligence.com/research-report/cardiac-mri-testing-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.